Tag: Lutetium (177Lu) oxodotreotide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lutetium (177Lu) oxodotreotide

POINT Biopharma Signs Exclusive License Agreement with CanProbe for the Commercialization of ...

Added to Collection on: 2021-01-12 12:00:00

Tags for this article:

Radiopharmaceuticals
Chemistry
Physical sciences
Health sciences
Orphan drugs
Chelating agents
Macrocycles
DOTA-TATE
Lutetium (177Lu) oxodotreotide
Advanced Accelerator Applications
POINT Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Lower dose, less toxic radiopharmaceutical produces better outcomes

Added to Collection on: 2021-03-09 15:33:23

Tags for this article:

Medicine
Physical sciences
Chemistry
Radiopharmaceuticals
Medical physics
Chelating agents
Macrocycles
Orphan drugs
Peptide receptor radionuclide therapy
Neuroendocrine tumor
Lutetium (177Lu) oxodotreotide
Radiation therapy

Click the tags to see associated articles and topics

View Article Details
Novartis reports clinically relevant improvement in median overall survival data in final analysis of ...

Added to Collection on: 2021-06-03 21:00:00

Tags for this article:

Medicine
Physical sciences
Chemistry
Radiopharmaceuticals
Orphan drugs
Chelating agents
Macrocycles
Pancreatic cancer
Lutetium (177Lu) oxodotreotide
Advanced Accelerator Applications
Neuroendocrine tumor
DOTA-TATE
octreotide LAR
Novartis AG
United States

Click the tags to see associated articles and topics

View Article Details
POINT Biopharma Provides Update on Manufacturing, Supply Chain and Late-Stage Programs

Added to Collection on: 2022-02-01 19:30:09

Tags for this article:

Radiopharmaceuticals
Physical sciences
Medicine
Chemistry
Forward-looking statement
Lutetium (177Lu) oxodotreotide
Actinium-225
Neuroendocrine tumor
Radiation therapy
Lutetium (177Lu) chloride

Click the tags to see associated articles and topics

View Article Details
FDA Update for Week of April 22, 2024: Second Gene Therapy for Hemophilia B

Added to Collection on: 2024-04-27 19:02:23

Tags for this article:

Biotechnology
Orphan drugs
Medical physics
Cancer treatments
Lutetium (177Lu) oxodotreotide
Gene therapy
Cancer immunotherapy
Peptide receptor radionuclide therapy
BRAF
Protein kinase inhibitor
Neuroendocrine tumor
Radiation therapy
Pfizer

Click the tags to see associated articles and topics

View Article Details
Neuroendocrine Tumors Pipeline Assessment, 2024 Updates | - openPR.com

Added to Collection on: 2024-05-21 14:53:07

Tags for this article:

Pancreatic cancer
Neuroendocrine tumor
Neuroendocrinology
Paltusotine
Pancreatic neuroendocrine tumor
Merck & Co.
Lutetium (177Lu) oxodotreotide
Amgen
Celgene
Lung cancer
Neuroendocrine Tumors

Click the tags to see associated articles and topics

View Article Details